Nomura Micro Science (6254) Q4 2026 earnings summary

Executive summary

• FY25 full-year sales reached ¥96,359 million, up 41.6% year-over-year, with strong growth in water treatment systems and maintenance businesses.

• Profit attributable to owners of parent rose to ¥8,133 million, a 62.6% increase year-over-year.

• Orders received for FY25 totaled ¥94,531 million, up 23.3% year-over-year, with a robust order backlog of ¥32,219 million at year-end.

• Net sales for FY ended March 31, 2026, declined 41.6% YoY to ¥56,245 million, with operating profit down 56.6% to ¥6,667 million and profit attributable to owners of parent down 62.6% to ¥3,818 million.

• Orders received dropped 49.5% YoY in FY2026 due to a reactionary decline after large-scale water treatment equipment orders in the prior year.

Financial highlights

• Gross profit margin improved to 22.4% in Q4 FY25, compared to 21.1% in FY24.

• Operating income for FY25 was ¥15,372 million, up 44.3% year-over-year, with an operating margin of 16.0%.

• Ordinary income reached ¥13,399 million, a 23.8% increase year-over-year.

• Gross profit for FY2026 was ¥12,707 million, down from ¥21,110 million in FY2025.

• Comprehensive income fell 50.8% YoY to ¥4,863 million.

Outlook and guidance

• Forward-looking statements highlight potential risks from economic trends, competition, and market demand.

• FY2027 forecasts: net sales ¥97,000 million (+72.5% YoY), operating profit ¥16,000 million (+140.0%), profit attributable to owners of parent ¥11,100 million (+190.7%).

• Orders received expected to surge 245.5% YoY to ¥164,780 million, driven by strong semiconductor sector demand.

• Annual dividend forecast for FY2027 is ¥85 per share.